Navigation Links
Life Technologies Sets 1st Quarter 2011 Earnings Release Date for Tuesday, April 26, 2011
Date:4/5/2011

CARLSBAD, Calif., April 5, 2011 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) announced today it will report its first quarter 2011 financial results on Tuesday, April 26, 2011, after market close. The company will also hold a webcast on the same day at 4:30 p.m. ET to discuss operating results, as well as future expectations.

(Logo:  https://photos.prnewswire.com/prnh/20110216/MM49339LOGO)

The webcast can be accessed through the investor relations page of the Life Technologies website at ir.lifetechnologies.com/events.cfm.  A replay of the webcast will be available on the Company's website through Tuesday, May 17, 2011.

About Life Technologies

Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific and medical advancements that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance the fields of discovery and translational research, molecular medicine, stem cell-based therapies, food safety and animal health, and 21st century forensics. The company manufactures both molecular diagnostic and research use only products. Life Technologies' industry-leading brands are found in nearly every life sciences lab in the world and include innovative instrument systems under the Applied Biosystems and Ion Torrent names, as well as, the broadest range of reagents with its Invitrogen, GIBCO, Ambion, Molecular Probes and Taqman products. Life Technologies had sales of $3.6 billion in 2
'/>"/>

SOURCE Life Technologies Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
2. RainDance Technologies Appoints Olex Vice President, System Development
3. Palatin Technologies, Inc. Reports Positive Results of Phase 2a Clinical Study with PL-3994 for the Treatment of Heart Failure
4. Reliant Technologies Announces Canadian Launch of Fraxel re:pair(R) Laser: A New Class of Treatment Therapy for CO2 Laser Skin Resurfacing
5. RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at ProHealth Cares Waukesha Memorial Hospital
6. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
7. Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration
8. Anthill Technologies Announces Agreement With Zafgen
9. Neptune Technologies Reports Record Fiscal 2008 Fourth Quarter and Year End Results
10. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
11. Neptune Technologies successfully completes up to $8.5 million debt financing with Desjardins Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Genedata, a leading provider of ... and life science research, today announced AB Enzymes ... its bioinformatics platform for strain genome data management ... AB Enzymes, one of the world’s oldest and ... Genedata Selector accompanied by bioinformatics consulting services. Genedata ...
(Date:5/22/2013)... Toronto, Ontario (PRWEB) May 22, 2013 ... of advanced sound therapy for tinnitus treatment. AudioNotch ... Destination Hearing . With clinic locations in both ... trusted provider of audiology and hearing services. AudioNotch's ... Zabell locations. , Upon entering a Destination Hearing ...
(Date:5/22/2013)... Express Diagnostics Int’l, Inc. (EDI) ... are pleased to announce a sponsorship agreement with Erebus ... Zealand distributor of DrugCheck® onsite testing devices, manufactured by ... the Austin 400 May 17-19 in Austin, Texas. , ... involves each car of the Erebus Motorsport team displaying ...
(Date:5/22/2013)... Envera announced today that Michael McErlean ... McErlean has an extensive background in cell production and ... career. , Mike Matheny, President and Owner ... Mike join our team”. “Mike’s background is perfectly suited ... and downstream processing equipment”, added Matheny. “Mike’s hands ...
Breaking Biology Technology:AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 2AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 3AB Enzymes Chooses Genedata Selector for Production Strain Development and Optimization 4AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing 2Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2Envera Appoints Michael McErlean Fermentation Manager 2
... 4 The Arcas Group, a leading ... Terwindt, MBA as Executive Vice President. He will assume ... previously served as President of Imedex, Inc."Stefan is an ... skills to our company," said Founder and President Jan ...
... Blakely & Company, LLC, a Boston-based life science investment ... III has joined the firm as senior advisor. ... firm on internal and client-related activities including private equity ... particular focus on medical device transactions. "We are ...
... Pharma Limited ("Circ Pharma") and,Elan Corporation plc ("Elan") ... Agreement to develop a chronotherapeutic formulation of Tramadol,for ... , The product incorporates ... dosing. Circ,s technology provides for,minimized delivery to the ...
Cached Biology Technology:The Arcas Group Appoints Executive Vice President 2Venture Capital Veteran John Brooks Joins Life Science Investment Bank Johnston Blakely & Company 2Circ Pharma Limited Enters Into Development Agreement for Chrono Tramadol With Elan Corporation Plc 2
(Date:5/21/2013)... that the nation,s land and water resources could likely ... to 25 billion gallons of algae-based fuel a year ... needs. , The findings come from an in-depth look ... grow significant amounts of algae in large, specially built ... 7 issue of Environmental Science and Technology , ...
(Date:5/21/2013)... Center today awarded 12 research grants, totaling nearly ... efforts. , The two-year grants of up to ... track the remediation of harmful algae blooms; assess ... plant invasions; study chromosomal damage in tree swallow ... , The grants were awarded to multidisciplinary teams ...
(Date:5/21/2013)... decades, scientists have developed many devices that can reopen ... generally effective, each of these treatments has drawbacks, including ... from MIT analyzes the potential usefulness of a new ... drug-releasing stents, but may pose fewer risks. With this ... for only a brief period, during which it releases ...
Breaking Biology News(10 mins):Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4U-M Water Center awards $570K in Great Lakes restoration grants 2U-M Water Center awards $570K in Great Lakes restoration grants 3U-M Water Center awards $570K in Great Lakes restoration grants 4Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3
... his findings on cancer research and treatment at the Egyptian ... Egyptian Cultural and Educational Bureau, will run from 6 p.m. ... Egyptian-born researcher and professor at Charles Drew University of Medicine ... for cancer for more than two decades. His research has ...
... frequently happens in science that what you throw away turns ... but not for long. The Rice assistant professor in ... cells in a scaffold, and he discarded the sticky substance ... contamination, so I threw the plates away," said Nagrath, then ...
... in adipose tissue may cause insulin resistance, and thereby type ... Karolinska Institutet, published in the New England Journal of ... fat is only pernicious. Instead the findings suggest that a ... cell turnover in the lean, healthy state. In ...
Cached Biology News:Your fat may help you heal 2Inflammation in body fat is not only pernicious 2
p27 rabbit polyclonal antibody...
UBC13 Antibody...
HLA II DG+DR+DP Monoclonal Antibody, Purified, Unconjugated, Clone: IQU9 This antibody is specific for the monomorphic determinant of the HLA Class II beta chains of the human MHC (28 kDa)....
Phenytoin-BSA Isolated IgY DFc Drug...
Biology Products: